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Abstract
Among the neuronal binding partners of calmodulin (CaM) are Munc13 proteins as essential presynaptic regulators that
play a key role in synaptic vesicle priming and are crucial for presynaptic short-term plasticity. Recent NMR structural
investigations of a CaM/Munc13-1 peptide complex have revealed an extended structure, which contrasts the compact
structures of most classical CaM/target complexes. This unusual binding mode is thought to be related to the presence of
an additional hydrophobic anchor residue at position 26 of the CaM binding motif of Munc13-1, resulting in a novel 1-5-8-26
motif. Here, we addressed the question whether the 1-5-8-26 CaM binding motif is a Munc13-related feature or whether it
can be induced in other CaM targets by altering the motif’s core residues. For this purpose, we chose skeletal muscle myosin
light chain kinase (skMLCK) with a classical 1-5-8-14 CaM binding motif and constructed three skMLCK peptide variants
mimicking Munc13-1, in which the hydrophobic anchor amino acid at position 14 was moved to position 26. Chemical
cross-linking between CaM and skMLCK peptide variants combined with high-resolution mass spectrometry yielded insights
into the peptides’ binding modes. This structural comparison together with complementary binding data from surface
plasmon resonance experiments revealed that skMLCK variants with an artificial 1-5-8-26 motif cannot mimic CaM binding
of Munc13-1. Apparently, additional features apart from the spacing of the hydrophobic anchor residues are required to
define the functional 1-5-8-26 motif of Munc13-1. We conclude that Munc13 proteins display a unique CaM binding
behavior to fulfill their role as efficient presynaptic calcium sensors over broad range of Ca2+ concentrations.
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Introduction
Calmodulin (CaM) is a small acidic protein and is one of the
most prominent Ca2+ sensors. It is ubiquitously found and
extraordinarily conserved from yeast to human [1]. CaM binds
to a large number of different intracellular proteins in a Ca2+
dependent or independent manner, including kinases, phospha-
tases, cytoskeletal proteins, and transcription factors. One impor-
tant example of neuronal CaM targets is present in Munc13
proteins, which constitute essential presynaptic regulators.
Munc13 proteins play a key role in synaptic vesicle priming and
are involved in presynaptic short-term plasticity (STP) [2,3,4]. The
binding of Munc13 to CaM was found to link residual Ca2+
signaling with the synaptic exocytotic machinery [5]. All Munc13
isoforms share a highly conserved C-terminal region, but possess
divergent N-termini with the CaM binding sites (see [6] for
overview). Munc13 peptides, comprising the CaM binding
regions, form 1:1 complexes with CaM already at submicromolar
Ca2+ concentrations [7]. Recently, we applied complementary
cross-linking strategies to gain first insights into the 3D-structures
of Munc13/CaM complexes and showed that 21-amino acid
Munc13 peptides bind the C-terminal CaM domain through a
classical antiparallel 1-5-8 CaM binding motif with the numbers
indicating the hydrophobic anchor residues of the motif [8,9].
Yet, a second interaction site was identified in the homologous
Munc13 isoforms Munc13-1 and ubMunc13-2 when CaM
binding of C-terminally elongated 34-amino acid Munc13-1 and
ubMunc13-2 peptides was studied by the complementary tech-
niques of photo-affinity labeling (PAL) and NMR spectroscopy.
Thereby, it was found that a tryptophan at position 26 of the CaM
binding motif anchors the C-termini of Munc13 peptides to the N-
terminal CaM domain, creating a novel, so-called ‘‘1-5-8-26
motif’’ with hydrophobic anchor amino acids at positions 1, 5, 8,
and 26 [10]. This motif is conserved in Munc13-1 and ubMunc13-
2 homologues from almost all species analyzed so far. The NMR
structure of the CaM/Munc13-1 peptide complex (PDB entry
2KDU) revealed a unique binding behavior of this longer
Munc13-1 peptide to CaM, with the peptide exhibiting an a-
helical part, such as in classical CaM targets, in addition to a
hairpin structure with a second CaM binding site. In this complex,
CaM shows an extended structure, which greatly differs from the
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structure that CaM exhibits in its complexes with classical CaM
targets in the presence of calcium.
In the present study, we investigated whether such a 1-5-8-26
CaM binding motif is unique for Munc13-1 and ubMunc13-2 or
whether it can be principally generated from other 1-5-8-based
motifs by C-terminal elongation and specific amino acid exchang-
es. For this purpose, we chose the well characterized CaM target
skeletal muscle myosin light chain kinase (skMLCK) as a prototype
of the 1-5-8-14 family of CaM binding motifs and modified it to
mimic the sequence of Munc13.
The interaction between CaM and skMLCK is crucial for
muscle contraction. Upon Ca2+ binding, CaM activates skMLCK
by interacting with the autoinhibitory sequence of the protein and,
thereby, inducing a domain movement. This allows skMLCK to
bind to its substrate myosin and to exert its function as kinase
[11,12]. The NMR structure of the CaM/skMLCK peptide
complex [13] shows that CaM collapses around the 26-amino acid
skMLCK peptide, called M13, comprising the CaM binding
region (Figure 1). The binding behavior of the skMLCK peptide
M13 to CaM in an antiparallel manner according to a 1-5-8-14
motif is comparable to that of short (21-amino acid) Munc13
peptides [8]. Therefore, the question arises, how the complex
between CaM and the C-terminally elongated skMLCK peptides
will be configured – collapsed or extended – in case they are
modified to mimic Munc13’s 1-5-8-26 motif.
In order to address this question we synthesized four skMLCK
peptides containing a C-terminally elongated CaM binding region
with single amino acid exchanges at positions 14 and 26 of the
CaM binding motif (Figure 1). Phe-19 of the skMLCK peptide
corresponds to position 14 of the CaM binding motif and
replacement of Phe-19 with an acidic glutamate residue mimics
the respective amino acid (Glu) in the Munc13-1 peptide. The
additional exchange of Leu-31 (corresponding to position 26 in the
CaM binding motif) to tryptophan results in the 1-5-8-26 motif
found in Munc13-1 and ubMunc13-2. For gaining detailed
information about the binding modes of the four skMLCK
peptide variants to CaM (Figure 1) we used chemical cross-linking
in combination with high-resolution mass spectrometry – a
technique that has matured into an alternative approach to derive
structural information of protein complexes [14,15,16]. Cross-
linking experiments were conducted with two cross-linkers yielding
complementary information: The homobifunctional amine-reac-
tive, isotope-labeled cross-linker BS2G (bis(sulfosuccinimidyl)gluta-
rate) with two N-hydroxysuccinimide (NHS) ester sites and the
heterobifunctional amine/photo-reactive cross-linker SBC (N-
succinimidyl-p-benzoyldihydrocinnamate) (Scheme S1 in File
S1). Additionally, we performed surface plasmon resonance
(SPR) measurements to investigate the effect of amino acid




CaM (bovine brain) was obtained from Calbiochem (Bad
Soden, Germany) and used without further purification. CaM was
confirmed by MALDI-TOF-MS to be N-terminally acetylated and
trimethylated at Lys-115; skMLCK peptides were synthesized by
standard fluorenylmethoxycarbonyl (Fmoc) chemistry as previous-
ly described [17]. The isotope-labeled cross-linking reagent
bis(sulfosuccinimidyl)glutarate (BS2G-D0 (non-deuterated) and
BS2G-D4 (four-times deuterated)) was purchased from Thermo
Fisher Scientific (Darmstadt, Germany); N-succinimidyl-p-benzoyl-
dihydrocinnamate (SBC) was synthesized in-house [18] (Scheme S1
in File S1). Trypsin (porcine, mass spectrometry grade or
sequencing grade modified) and the trypsin enhancer Protease-
MaxTM Surfactant were purchased from Promega (Mannheim,
Germany). Nano-HPLC solvents were spectroscopic grade
(Uvasol, VWR, Darmstadt, Germany). Water was purified with
a Pacific-UP/UPW water purification system (Thermo Fisher
Scientific-TKA, Niederelbert, Germany). All other chemicals were
purchased from Sigma (Taufkirchen, Germany).
Chemical Cross-linking
For all cross-linking reactions, CaM was diluted to 10 mM in
20 mM HEPES buffer (pH 7.2) containing a Ca2+/chelator
(EGTA) system, with free Ca2+ concentrations adjusted between
0 nM to 50 mM as described previously [18]. Initially, different
calcium concentrations were used in a calcium titration experi-
ment with BS2G-D0 (Scheme S1 in File S1). The diluted CaM
solution (10 mM) was mixed with 10 mM of the respective
skMLCK peptide (in 20 mM HEPES, pH 7.2) and incubated
for 15 min. To start the cross-linking reaction, BS2G (in DMSO)
was added in a 50-fold molar excess to the protein solution. After
an incubation time of 60 min, the reaction was quenched by
adding NH4HCO3 to a final concentration of 20 mM. For the
cross-linking reactions with BS2G presented herein, Ca2+ concen-
trations of 30 nM and 1 mM were used. The workflow was the
same as for the Ca2+ titration experiment described above, except
that BS2G was used in a D0/D4 (1:1) mixture to facilitate MS
identification of cross-linked products by their characteristic
isotope patterns. The cross-linking reactions with SBC were
conducted in a two-step fashion [18]. First, the amine-reactive
NHS ester site of SBC was allowed to react with CaM for 30 min
after adding a 50-fold molar excess of a freshly prepared solution
of SBC in DMSO to the 10 mM CaM solution. Quenching of non-
reacted NHS ester sites of SBC was carried out with NH4HCO3
(20 mM final concentration). Afterwards, non-reacted SBC was
removed by microfiltration with YM-10 centrifugation units or
Amicon Ultra centrifugal units (10 K) (Millipore, Schwalbach,
Germany). For the photo-cross-linking reaction, the respective
skMLCK peptide (10 mM) was mixed with SBC-labeled CaM
before irradiating the mixture with UV-A light (maximum at
365 nm) in a home-built device [19]. 200 ml-aliquots were taken at
irradiation energies of 4 and 8 J/cm2 and concentrated by
microfiltration as described above. The eluates were stored at
220uC before MS analysis was performed.
Figure 1. Amino acid sequences of peptides representing the
CaM binding motifs of Munc13-1 and skMLCK. Numbers of N-
terminal amino acids refer to full length proteins. The peptides used in
this study are skMLCK, skMLCK F19A, skMLCK F19E and skMLCK F19E/
L31W. Hydrophobic anchor amino acids are shown in bold and
underlined, the numbers above the amino acid sequences indicate
their respective positions in the CaM binding motif.
doi:10.1371/journal.pone.0075119.g001
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MALDI-TOF-MS of CaM/skMLCK Peptide Complexes
After desalting the solutions containing the cross-linked CaM/
peptide complexes (ZipTip C4, Millipore, Schwalbach, Germany),
1.2 ml of the respective solution was mixed with 1.2 ml of 2,5-
dihydroxybenzoic acid (DHB, Sigma) as matrix (20 mg/ml) in
50% (v/v) acetonitrile (ACN) and 0.1% (v/v) trifluoroacetic acid
(TFA) and prepared on a steel target. MALDI-TOF-MS
measurements were conducted on an Ultraflex III MALDI-
TOF/TOF mass spectrometer (Bruker Daltonik, Bremen, Ger-
many) in linear and positive ionization mode. Spectra in the m/z
range 7,000–33,000 were acquired using FlexControl version 3.3
and processed with FlexAnalysis version 3.3 (Bruker Daltonik).
Gel Electrophoresis and In-Gel Digestion
Cross-linked CaM/skMLCK peptide complexes were separated
from non-reacted CaM using one-dimensional sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (15%
resolving gel) [20]. After staining with Coomassie Brilliant Blue
R250, gel bands of interest were excised and washed as published
previously [21]. In-gel digestion with trypsin (240 ng per gel band)
and the trypsin enhancer ProteaseMaxTM Surfactant was
performed according to the manufacturer’s instructions for
2 hours at 37uC.
Nano-HPLC/nano-ESI-LTQ-Orbitrap-MS/MS
Tryptic peptide mixtures were fractionated on an Ultimate
nano-HPLC system equipped with Famos autosampler and
Switchos II (LC-Packings/Dionex, Idstein, Germany) using a
trapping column (Acclaim PepMap, C18, 100 mm620 mm, 5 mm,
100 A˚, Dionex) for desalting (15 min, 0.1% (v/v) TFA) followed
by a separation column (Acclaim PepMap, C18, 75 mm6200 mm,
3 mm, 100 A˚, Dionex) with a 90-min gradient of 0–50% B (A: 5%
(v/v) ACN containing 0.1% (v/v) formic acid (FA); B: 80% (v/v)
ACN containing 0.08% (v/v) FA). The nano-HPLC system was
directly coupled to the nano-ESI source (Proxeon, Odense,
Denmark) of an LTQ-OrbitrapXL mass spectrometer (Thermo
Fisher Scientific, Bremen, Germany) that was operated in positive
ionization mode. Data dependent MS/MS (collision-induced
dissociation, CID) experiments (isolation window 2.5 Th) were
conducted in the linear ion trap (LTQ) of the five most abundant
signals of the full MS scan in the orbitrap (R = 60,000). Detection
of less abundant peaks was enabled using dynamic exclusion
(exclusion duration 120 s, after three repeats of fragmentation of
one precursor). Data acquisition was controlled via XCalibur 2.0.7
(Thermo Fisher Scientific, Bremen, Germany) in combination
with DCMS link 2.0 (Dionex, Idstein, Germany).
Analysis of Cross-linked Products
Cross-linked products were identified by analyzing MS and
MS/MS data with the in-house software StavroX 2.0.6. [22] and
XCalibur 2.0.7 (Thermo Fisher Scientific, Bremen, Germany).
Generation of protein structures and docking of apo-CaM (PDB
entry 2L53, aa 1–77; [23]) with holo-CaM (PDB entry 2BBM, aa
78–148; [13]) was performed with open-source Pymol 0-99rc6
(DeLano Scientific, San Francisco).
CD Spectroscopy
Peptides were dissolved in phosphate buffer (100 mM
K2HPO4/KH2PO4, pH 7.5) at a concentration range of 70–
130 mM and final concentrations were determined spectrophoto-
metrically at 280 nm. Far-UV CD measurements in the presence
of increasing 2,2,2-trifluoroethanol (TFE) concentrations were
performed at 4uC in a 0.5 mm fused silica cuvette on a Jasco J-810
spectropolarimeter. Up to 20 single far-UV CD spectra were
accumulated from 200 to 260 nm with a scan rate of 20 nm/min,
4 s-response, and a band width of 1 nm.
Surface Plasmon Resonance (SPR) Spectroscopy
The affinities of the different skMLCK variants for CaM were
examined by SPR measurements using a Biacore T100 SPR
instrument (GE Healthcare, Freiburg, Germany); skMLCK
peptides were N-terminally biotinylated using EZ-Link NHS-LC-
Biotin (Thermo Fisher Scientific, Darmstadt, Germany) with
peptide: biotinylation reagent ratios ranging between 1:10 and
10:1 (w/w). The biotinylation reaction was conducted in PBS
buffer (pH 6.5) for 30 min on ice, excess of NHS-LC-Biotin was
quenched with 10–20 mM NH4HCO3 (final concentration), and
removed by microfiltration using Amicon Ultra centrifugal units
(10 kDa cutoff, Millipore, Schwalbach, Germany). MALDI-TOF-
MS was used to check for N-terminal biotinylation of all skMLCK
peptide variants. The peptides were immobilized on a Series S
Sensor Chip SA (GE Healthcare, Freiburg, Germany), which was
previously conditioned by three consecutive 1-min injections of a
solution containing 1 M NaCl and 50 mM NaOH. Peptide
solutions were injected at a flow rate of 5 ml/min until an
immobilization level of 350 response units (RU) was reached. For
the skMLCK F19E peptide, the maximum immobilization level
was 250 RU. CaM was diluted in running buffer (20 mM HEPES
buffer (pH 7.4) containing 150 mM NaCl, 1 mM CaCl2, and
0.05% (v/v) Tween20) to concentrations between 100 pM and
750 nM and injected over the chip surface at a flow rate of 12 ml/
min for 1750 s. Running buffer was used as blank. Regeneration
of the chip was performed with 20 mM HEPES buffer (pH 7.4)
containing 10 mM EGTA and 0.05% (v/v) Tween20 for 2 min at
a flow rate of 12 ml/min. The temperature was set to 25uC.
Response data were double referenced and averaged over 10 s at
the end of the association injection to calculate steady-state
responses. KD values were determined by fitting equation 1 to
steady-state data using SigmaPlot 11.0 (Systat Software, Inc.)
Req~Rmax  C= KDzCð ÞzN  C ðeq:1Þ
with Req: steady-state response, KD: equilibrium dissociation
constant, C: CaM concentration, Rmax: saturation binding response
of high-affinity binding phase, and N: slope of observed linear
binding phase.
Results
Design of skMLCK Peptide Variants
For comparing the binding behavior between Munc13 and
CaM to that of the classical CaM target skMLCK, we chose a 33-
amino acid sequence stretch representing the CaM binding region
of skMLCK. Compared to the so called M13 peptide, comprising
solely the CaM binding region of skMLCK [13], the skMLCK
peptides used herein are C-terminally elongated and contain
specific amino acid exchanges at position(s) 14 or/and 26 of the
CaM binding motif (corresponding to positions 19 and 31 in the
amino acid sequence; Figure 1). Classical CaM binding motifs are
1-5-8-14 motifs with hydrophobic anchor amino acids at positions
1, 5, 8, and 14. However, Munc13-1 and ubMunc13-2 exhibit a 1-
5-8-26 motif, which results in an exceptional CaM binding
behavior [10]. Therefore, we aimed to address the question
whether removal of the anchor amino acid at position 14 together
with a second interaction site at position 26 of the CaM binding
motif – as in Munc13 peptides – can induce a structure in a
classical CaM/target complex comparable to that of the CaM/
CaM Binding of Munc13-Like skMLCK Variants
PLOS ONE | www.plosone.org 3 October 2013 | Volume 8 | Issue 10 | e75119
Munc13-1 complex. The skMLCK peptide was converted in this
respect that the hydrophobic anchor phenylalanine at position 14
of the CaM binding motif was exchanged to alanine and
glutamate, respectively. Additionally, the leucine residue at
position 26 of the motif was exchanged to a comparably
hydrophobic, but more bulky tryptophan residue. A glutamate
at position 14 and a tryptophan at position 26 strongly resemble
the Munc13-1 CaM binding motif (Figure 1).
Secondary Structures of skMLCK Peptide Variants
Usually, CaM target motifs possess a high propensity to form a-
helices - as do the Munc13 peptides [24]. Therefore, we performed
CD measurements to compare the secondary structures of
skMLCK peptide variants among themselves as well as with those
of the Munc13 peptides [9]. As expected, an a-helical structure is
induced in the C-terminally elongated skMLCK peptide in the
presence of increasing TFE concentrations, reaching a maximum
a-helical content at 40% TFE (Figure S1A in File S1). CD studies
conducted with skMLCK F19A and skMLCK F19E revealed
similar results (Figure S1B, C in File S1), indicating that an amino
acid exchange at position 14 of the skMLCK CaM binding motif
does not result in major changes in secondary structure. On the
other hand, CD measurements confirmed a dramatically reduced
propensity of skMLCK F19E/L31W to form an a-helical structure
(Figure S1D in File S1), as secondary structure prediction
(PSIPRED) had indicated. These findings demonstrate that the
exchange of Leu-31 in the skMLCK peptide to a bulky
hydrophobic tryptophan causes remarkable structural changes in
the peptide, raising the question whether this has an influence on
the structure of the resulting CaM/peptide complex.
Ca2+ Dependence of CaM/skMLCK Interaction
Before conducting the cross-linking experiments for 3D-
structural analysis of CaM/peptide complexes, we performed
Ca2+ titration experiments to investigate the influence of Ca2+ on
CaM/skMLCK peptide complex formation. Figure 2A shows an
SDS gel of cross-linking reactions with Ca2+ concentrations
ranging from 0 to 50 mM. It is readily visible that 1:1 complexes
between CaM and the skMLCK peptide are created with the
cross-linker BS2G both at low and higher Ca2+ concentrations; yet,
the CaM/skMLCK peptide complexes created at resting, i.e.,
nanomolar, Ca2+ concentrations seem to be different from those
created at higher Ca2+ concentrations [25]. A dramatic change in
the electrophoretic mobility of CaM is detected at Ca2+
concentrations between 100 nM and 100 mM due to a conforma-
tional change in CaM upon calcium binding (KD (C-terminal lobe
of CaM): 2 ? 1027 M; KD (N-terminal lobe of CaM): 2 ? 10
26 M
[26]). Moreover, at higher Ca2+ concentrations (.100 mM) there
are several bands visible corresponding to different cross-linked
species (both intramolecular cross-links in CaM as well as
intermolecular cross-links between CaM and the peptide) exhib-
iting slightly different electrophoretic mobilities. Subsequent cross-
linking experiments were conducted at two different Ca2+
concentrations, 1 mM and 30 nM (Figure 2B and Figure S2 in
File S1), in order to investigate the binding behavior of skMLCK
peptides to CaM both in the low and the high calcium range.
Cross-linking of CaM/skMLCK Complexes
The cross-linking reactions were conducted with the homo-
bifunctional amine-reactive cross-linker BS2G, which reacts
mainly with lysine residues, but also with serines, tyrosines, or
threonines [27,28]. Additionally, we used the heterobifunctional
amine/photo-reactive cross-linker SBC [18]. The photo-reaction
is less specific compared to that of NHS esters and yields a number
of potential cross-linking sites. Although the benzophenone moiety
might preferably react with methionines after irradiation with
long-wavelength UV light (,365 nm) [18,29], alternative residues,
such as Ala, Phe, Ile, Leu, Lys, and Arg, are susceptible for the
cross-linking reaction with SBC. This presents a distinct advantage
for investigating protein interaction sites as a less specific cross-
linking reaction will result in a greater variety of cross-linked
products.
Intact BS2G-cross-linked CaM/skMLCK peptide complexes
were analyzed by MALDI-TOF mass spectrometry (Figure S3 in
File S1), showing a reasonable amount of cross-linked CaM/
skMLCK peptide (1:1) complex at 1 mM Ca2+. This was
confirmed by analyzing BS2G- and SBC-cross-linked complexes
by gel electrophoresis (SDS-PAGE), with reactions conducted at
Ca2+ concentrations of 1 mM and 30 nM (Figure 2B). CaM
modified with partially hydrolyzed cross-linker (in the case of
BS2G) as well as intramolecularly cross-linked CaM possess
molecular weights around 17 kDa. These various cross-linker-
modified species exhibit different electrophoretic mobilities in
SDS-PAGE analysis, resulting in several bands in the presence of
high Ca2+ concentrations (Figure 2A). At low Ca2+ concentrations
(0–100 nM), two distinct bands are visible for intramolecularly
cross-linked CaM and CaM/skMLCK peptide (1:1) complexes
(Figures 2A, B; Figure S2 in File S1). The bands of cross-linked
CaM/skMLCK peptide (1:1) complexes and of cross-linker
modified and/or intramolecularly cross-linked CaM were excised
from the gel, subjected to in-gel digestion, and analyzed by nano-
HPLC/nano-ESI-LTQ-Orbitrap-MS/MS (Figures 3 and 4). The
number of identified intra- and intermolecular cross-linked
products varied between different cross-linking experiments
(Table 1 and Tables S1, S2, S3, and S4 in File S1).
3D-Structure of the CaM/skMLCK Complex
Identification of cross-linked products between CaM and the
skMLCK peptide was performed by nano-HPLC/nano-ESI-
LTQ-Orbitrap-MS/MS (Figure 3). The products resulting from
the cross-linking reaction with BS2G conducted at 1 mM Ca2+ are
in agreement with the published NMR structure of the CaM/
skMLCK peptide (M13) complex [13] as illustrated in Figures
S4A, B in File S1 (see also Table S1 in File S1). Following earlier
work, Ca–Ca distances up to 19 A˚ (or even 25 A˚) can be assumed
as constraints from chemical cross-linking experiments with
reagents possessing spacer lengths of up to 11 A˚, such as BS2G
and SBC [18,30]. Some slightly longer distances can be explained
by CaM’s inherent flexibility, especially in the a-helical linker
region that connects both lobes. The amino acids of CaM that
were found to be connected with the skMLCK peptide are
comparable to those detected in a previous cross-linking study, in
which Lys-21 and 30 in the N-terminal lobe of CaM as well as Lys-
75 and 77 in the central a-helix, and Lys-94 in the C-terminal lobe
of CaM had been cross-linked with the skMLCK peptide M13
[31]. Interestingly, several cross-linked products include the C-
terminal amino acid of CaM (Lys-148), which is quite unusual
compared to our previous experiences in studying CaM/peptide
complexes [21,31]. Figure S4C in File S1 shows the distances of
cross-linked amino acids in the NMR structure of the CaM/
Munc13-1 peptide complex [10], clearly indicating that this
structure does not exist for the CaM/skMLCK peptide complex
(PDB entry 2BBM). We analyzed intermolecular (between CaM
and the skMLCK peptide) as well as intramolecular (within CaM)
cross-linked products; yet, almost none of the cross-links were in
agreement with the structure of the CaM/Munc13-1 peptide
complex. This indicates that the complex between CaM and the
C-terminally elongated skMLCK peptide is structurally different
CaM Binding of Munc13-Like skMLCK Variants
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from the CaM/Munc13 peptide complex. Also at 30 nM Ca2+,
the cross-links are consistent with the NMR structure of the CaM/
M13 skMLCK peptide (Table S1 in File S1).
3D-Structure of the CaM/skMLCK F19A Complex
For the cross-linking reaction between CaM and skMLCK
F19A peptide (Table S2 in File S1), a lower number of cross-links
was found compared to the CaM complex with the skMLCK
peptide (Table S1 in File S1). However, the detected cross-linked
products lead to the same conclusion as for the skMLCK peptide
(Figure S5 in File S1): Especially the cross-link between the N-
terminal lobe of CaM (Lys-21) and skMLCK F19A peptide
exhibits a distance in the structure of the CaM/Munc13-1
complex the cross-linker BS2G is not able to bridge. This clearly
demonstrates that the unusual structure of the CaM/Munc13
peptide complex does not exist for the complex between CaM and
skMLCK F19A peptide (Figure S5C in File S1). Apparently,
removing the bulky, hydrophobic anchor amino acid at position
14 of the CaM binding motif, mimicking a 1-5-8-26 motif, does
not induce a structure comparable to that of the CaM/Munc13
peptide complex.
3D-Structure of the CaM/skMLCK F19E Complex
Nano-HPLC/nano-ESI-LTQ-Orbitrap-MS/MS analysis led to
the identification of a number of cross-linked products between
CaM and the skMLCK F19E peptide (Table S3 in File S1).
Almost all distances between cross-linked amino acids in CaM and
skMLCK F19E peptide at 1 mM Ca2+ are in agreement with the
structure of the CaM/M13 skMLCK peptide complex (Figures
S6A, B in File S1). The few distances that are slightly longer than
the expected maximum Ca-Ca distance of ca. 25 A˚ the cross-
linkers are able to bridge can be explained by the inherent
flexibility of CaM’s central a-helix (Lys-75 and 77). Although the
hydrophobic anchor amino acid Phe at position 14 of skMLCK’s
CaM binding motif is exchanged to an acidic glutamate, which
present in the CaM binding motif of Munc13-1 (Figure 1), the
unusual structure of the CaM/Munc13-1 peptide complex is
apparently not induced by this amino acid exchange.
3D-Structure of the CaM/skMLCK F19E/L31W Complex
To exclude that the extended conformation of CaM is
exclusively formed in the presence of a bulky hydrophobic amino
acid at position 26 of the CaM binding motif, we exchanged the
leucine at position 31 of the peptide to tryptophan in order to
mimic Munc13-1 (Figure 1). Analysis of the cross-links between
CaM and the skMLCK F19E/L31W peptide resulted in the
identification of a number of cross-linked products (Table 1 and
Table S4 in File S1). As an example, the SBC-cross-linked product
between Lys-94 of CaM and Leu-1 of skMLCK F19E/L31W
peptide is presented in Figure 4. Both lysine residues in the C-
terminal (Lys-94, Lys-148) and N-terminal CaM domains (Lys-13,
Lys-21) had reacted with the N-terminus of the skMLCK F19E/
L31W peptide (Leu-1, Met-2, Lys-3, Arg-4) indicating a collapsed
conformation of CaM in the complex (Figure 5). Apparently, not
even a skMLCK peptide that highly resembles the amino acid
sequence of the CaM binding motif of Munc13 can induce an
extended structure comparable to that of the CaM/Munc13
peptide complex (PDB entry 2KDU).
Surface Plasmon Resonance (SPR) Spectroscopy
In addition to the cross-linking experiments, we performed SPR
analysis to characterize the binding of skMLCK peptide variants
to CaM. The dissociation constant (KD) of the skMLCK M13
peptide for CaM binding is in the low nanomolar range [32],
which is comparable to that of the Munc13-1 peptide as proposed
by NMR titration experiments [10]. The C-terminally elongated
skMLCK peptide used in our study also exhibits a KD value in the
low nanomolar range (4.2 (60.6) nM, Figure 6A), showing that the
additional C-terminal residues of the skMLCK peptide do not
influence its CaM binding behavior. Besides this high-affinity
phase, the CaM-dependent steady-state response revealed a
second linear phase, indicating a low-affinity binding event. In
previous studies, low-affinity binding of a second peptide to CaM
had been observed for Munc13 peptides [7,8], suggesting the
presence of an alternative target binding region in CaM. In
contrast, the phenylalanine residue at position 14 of the CaM
binding motif is crucial for skMLCK binding, as evidenced by the
KD of skMLCK F19A (85 (69) nM, Figure 6B). Apparently, the
exchange of the hydrophobic anchor amino acid phenylalanine to
an acidic glutamate - resembling the CaM binding motif of
Figure 2. SDS-PAGE of cross-linking reaction mixtures between CaM and skMLCK peptides. (A) Cross-linking reactions between CaM and
skMLCK peptide (50-fold molar excess of BS2G, Ca2+ concentrations: 0 to 50 mM). As a control, CaM was diluted in water without adding buffer, EGTA,
or Ca2+; please note the different Ca2+-loaded states of CaM (lane 10). (B) Cross-linking reactions between CaM and the skMLCK F19E/L31W peptide,
conducted at 50-fold molar excess of SBC. Lanes 1–3: 1 mM Ca2+; lanes 5–7: 30 nM Ca2+. M: protein marker.
doi:10.1371/journal.pone.0075119.g002
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Munc13-1 - dramatically reduces the CaM affinity of this
skMLCK variant. Here, only the low-affinity binding event is
observed, while the high-affinity binding event is no longer
detectable in the concentration range investigated herein
(Figure 6C). A similar binding behavior is observed for the
skMLCK variant with an additional exchange (Leu-31RTrp)
(Figure 6D), suggesting that the tryptophan introduced at position
26 of the CaM binding motif cannot act as a second anchor
residue.
Discussion
We investigated the 3D-structures of complexes between CaM
and skMLCK peptide variants mimicking the CaM binding motif
Figure 3. Nano-HPLC/nano-ESI-LTQ-Orbitrap-MS/MS analysis of a cross-linked peptide mixture between CaM and skMLCK peptide.
The reaction was conducted at 1 mM Ca2+ with a 50-fold molar excess of BS2G for 60 min. (A) Mass spectrum (MS) obtained at an LC retention time of
70.42 min. The 4+ charged signal of a cross-linked product at m/z 783.398 is shown enlarged. (B) Fragment ion mass spectrum (CID-MS/MS). The
cross-linked product comprises amino acids 14–30 of CaM (a-peptide in red) and amino acids 8–18 of skMLCK (b-peptide in blue), in which Lys-21 of
CaM is connected to Lys-8 of skMLCK.
doi:10.1371/journal.pone.0075119.g003
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of Munc13 by chemical cross-linking in combination with mass
spectrometry. In order to mimic the unique 1-5-8-26 CaM motif
of Munc13-1, we exchanged the hydrophobic anchor amino acid
Phe-14 of the CaM-binding motif in skMLCK to alanine and
glutamate, respectively. Additionally, the leucine residue at
position 26 of the motif was changed to tryptophan, creating a
1-5-8-26 motif similar to that of Munc13-1. We show that the
distance constraints imposed by the chemical cross-links in all
CaM/skMLCK peptide complexes agree well with the published
NMR structure of the CaM/M13 skMLCK peptide complex
(PDB entry 2BBM) [13]. In this structure, CaM is collapsed
around the peptide, which brings the two lobes close to each other
Figure 4. Nano-HPLC/nano-ESI-LTQ-Orbitrap-MS/MS analysis of a cross-linked peptide mixture between CaM and skMLCK F19E/
L31W peptide. The reaction was conducted at 1 mM Ca2+ with a 50-fold molar excess of SBC (30 min, irradiation 8 J/cm2,). (A) Mass spectrum (MS)
obtained at an LC retention time of 59.94 min. The 4+ charged signal of a cross-linked product at m/z 635.077 is shown enlarged. (B) Fragment ion
mass spectrum (CID-MS/MS). The cross-linked product comprises amino acids 91–106 of CaM (a-peptide in red) and amino acids 1–4 of skMLCK F19E/
L31W (b-peptide in blue), in which Lys-94 of CaM is connected to Leu-1 of skMLCK F19E/L31W.
doi:10.1371/journal.pone.0075119.g004
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(Figures 5A, B, Figures S4A, B; S5A, B; S6A, B in File S1) and
allows bridging the distances between N- and C-terminal CaM
domains by both cross-linkers used herein. Compared to this
collapsed form, the conformation of CaM in the CaM/Munc13-1
peptide complex (PDB entry 1KDU) is more extended [10]. Here,
the distances between N- and C-terminal lobes of CaM are much
longer, making it impossible for both cross-linkers to connect
amino acids between the two CaM domains. The cross-links found
Table 1. Summary of cross-linked products (intra- and intermolecular) for CaM and skMLCK F19E/L31W peptide.
m/z measured [M+H]+theor. [Ca2+] CaM skMLCK E19/W31 Sample
527.507 2107.009 1 mM K77 L1, M2 SBC4
596.051 2381.185 1 mM K94 L1, M2 SBC4, SBC8
603.552 2411.188 1 mM K21 R4, R5 SBC8
608.551 2431.185 (1 Met oxid.) 1 mM K13 K3 BS2G
618.557 2471.205 30 nM, 1 mM K21 L1, M2 SBC4, SBC8
621.296 2482.161 30 nM K77 L1, M2 SBC8
635.077 2537.286 1 mM K94 L1 SBC8
870.757 2610.258 30 nM/1 mM K75 L1, M2 SBC4
657.582 2627.306 1 mM K21 L1, M2 SBC4, SBC8
1044.802 3132.389 (1Met oxid.) 30 nM/1 mM K148 L1, M2 SBC4, SBC8
640.132 3196.633 30 nM K94 L1, M2 SBC4
828.168 3309.654 30 nM K94 A12, V13 SBC4
850.674 3399.672 1 mM K21 A16 SBC4, SBC8
945.675 3779.676 1 mM K148 S23, S24 BS2G
975.254 4872.240 (3 Met oxid.) 30 nM/1 mM K75 L1 SBC4, SBC8
doi:10.1371/journal.pone.0075119.t001
Figure 5. Identified cross-linked products between CaM and the skMLCK F19E/L31W peptide. Distances between cross-linked amino
acids (at 1 mM Ca2+) are presented in the NMR structures of (A, B) CaM/M13 skMLCK peptide complex (PDB entry 2BBM, [13]; viewed from two angles
and (C) CaM/Munc13-1 peptide complex (PDB entry 2KDU, [10]). CaM is colored in grey, the peptide is shown in yellow. Reacted amino acids in CaM
are displayed as green sticks and those of the peptide are shown in purple. (D) Distances of cross-linked amino acids identified at 30 nM Ca2+
displayed in the half-loaded CaM (N-terminal domain of apo-CaM (PDB entry 2L53 [23], aa 1–77; green) and C-terminal domain of holo-CaM (PDB
entry 2BBM [13], aa 78–147; grey)). The skMLCK F19E/L31W peptide is shown in rainbow colors. Distances (in A˚) between Ca atoms of connected
amino acids are illustrated as dotted lines.
doi:10.1371/journal.pone.0075119.g005
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at a high Ca2+ concentration consistently point to the CaM/M13
skMLCK peptide structure (Figures 5A and B; Figures S4A, B;
S5A, B; S6A, B in File S1). At Ca2+ concentrations in the
nanomolar range, CaM is only half-saturated with Ca2+. In order
to investigate whether the cross-links found at 30 nM Ca2+ are in
agreement with a half Ca2+-loaded CaM structure, we docked the
N-terminus of apo-CaM (PDB entry 2L53, [23]) with the C-
terminus of holo-CaM (PDB entry 2BBM, [13]). The majority of
cross-links are consistent with this half Ca2+-loaded CaM structure
indicating that CaM might adopt a similar conformation, i.e., a
mixed apo-/holo-form, when binding to the skMLCK peptide at
low Ca2+concentrations (Figure 5D). On the other hand, our cross-
linking data do not exclude the possibility that the CaM/skMLCK
(M13) peptide complex exhibits identical structures at low and
high Ca2+ concentrations. Overall, our cross-linking results do not
support the extended conformation of CaM that is present in the
complex with Munc13-1 - even if the CaM binding motif of
skMLCK is changed to highly resemble that of Munc13-1 [10].
Furthermore, we performed SPR measurements to determine
the CaM binding affinities of the skMLCK peptide variants used
herein. We found a reduced CaM affinity for the skMLCK F19A
peptide (Figure 6B) where the bulky phenylalanine is exchanged to
alanine. The CaM binding affinity is drastically reduced if this
phenylalanine is exchanged to glutamate (Figure 6C) and if the
leucine at position 31 is additionally exchanged to tryptophan
(Figure 6D). Recently, a general model was proposed for the
conformation CaM can adopt in its complexes, relying on the
distance between the first and second bulky hydrophobic anchor
residue [33]. This model implies that a continuous a-helix is
created between the two anchor amino acids. In case of Munc13
peptides, a hairpin structure is formed, underlining the atypical
character of the 1-5-8-26 CaM binding motif present in Munc13.
Intriguingly, we did not identify a 1-5-8-26 motif comparable to
that of Munc13-1 when mining a CaM target database (32) and a
recent protein array screen of neuronal CaM-binding proteins
(33). Therefore, we conclude that the 1-5-8-26 CaM binding motif
of Munc13 is unique and induces an unusual conformation of the
complex, i.e., an extended structure with a modular architecture.
At least for Munc13-1 and ubMunc13-2, this is likely to be the
structural basis for a sequential CaM binding mode (10), and as
such for the ability of Munc13-CaM complexes to sense Ca2+ over
a broad concentration range.
Figure 6. SPR analysis of CaM binding to skMLCK peptides. The CaM-dependent steady-state response is shown for (A) skMLCK peptide, (B)
skMLCK F19A, (C) skMLCK F19E, and (D) skMLCK F19E/L31W. Solid lines indicate the results of fitting the data according to eq (1) (for (A) and (B)) or a
linear fit (for (C) and (D)). Dissociation constants (KD) with standard errors are given for (A) and (B) resulting from two independent measurements
(open and filled circles). RU: response unit; RUmax: maximum response unit reached during the measurement.
doi:10.1371/journal.pone.0075119.g006
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Supporting Information
File S1 Figure S1, CD experiments with different TFE
concentrations. (0–50%) of A) skMLCK peptide, B) skMLCK
F19A, C) skMLCK F19E, D) skMLCK F19E/L31W. Figure S2,
SDS-PAGE of cross-linking experiments of CaM and
skMLCK, skMLCK F19A, and skMLCK F19E. Cross-
linking reactions were carried out at a 50-fold molar excess of
BS2G with a Ca2+ concentrations 30 nM. Lane 10: As a control,
CaM was diluted in water without adding buffer, EDTA, or Ca2+;
please note the different Ca2+-loaded states of CaM. M: protein
marker. Figure S3, MALDI-TOF mass spectrum (MS) of
the cross-linking reaction mixture between CaM and
skMLCK F19E peptide (30 min incubation time, 1 mM
Ca2+, 50-fold molar excess of BS2G). Singly (m/z range
16,000–21,000) and doubly (m/z range 8,000–11,000) charged
ions of non-cross-linked CaM modified with partially hydrolyzed
cross-linker molecules and CaM/skMLCK (1:1) peptide complex-
es are visible. XL: cross-linker; n.a.: not assigned. Figure S4,
Identified cross-linked products (cross-linkers BS2G and
SBC) between CaM and the skMLCK peptide at 1 mM
Ca2+. Distances between cross-linked amino acids are presented
in the NMR structures of (A, B) the CaM/M13 kMLCK peptide
complex (PDB entry 2BBM, [13]; viewed from two angles) and (C)
the CaM/Munc13-1 peptide complex (PDB entry 2KDU, [10]).
CaM is colored in grey, the peptide is shown in yellow. Reacted
amino acids in CaM are displayed as green sticks, reacted amino
acids in the peptide are shown in purple. Distances (in A˚) between
Ca atoms of connected amino acids are shown as dotted lines.
Figure S5, Identified cross-linked products (cross-link-
ers BS2G and SBC) between CaM and the skMLCK F19A
peptide at 1 mM Ca2+. Distances between cross-linked amino
acids are presented in the NMR structures of (A, B) the CaM/M13
skMLCK peptide complex (PDB entry 2BBM, [13]; viewed from
two angles) and (C) the CaM/Munc13-1 peptide complex (PDB
entry 2KDU, [10]). CaM is colored in grey, the peptide is shown
in yellow. Reacted amino acids in CaM are displayed as green
sticks, reacted amino acids in the peptide are shown in purple.
Distances (in A˚) between Ca atoms of connected amino acids are
shown as dotted lines. Figure S6, Identified cross-linked
products (cross-linkers BS2G and SBC) between CaM
and the skMLCK F19E peptide at 1 mM Ca2+. Distances
between cross-linked amino acids are presented in the NMR
structures of (A, B) the CaM/M13 skMLCK peptide complex
(PDB entry 2BBM, [13]; viewed from two angles) and (C) the
CaM/Munc13-1 peptide complex (PDB entry 2KDU, [10]). CaM
is colored in grey, the peptide is shown in yellow. Reacted amino
acids in CaM are displayed as green sticks, reacted amino acids in
the peptide are shown in purple. Distances (in A˚) between Ca
atoms of connected amino acids are shown as dotted lines.
Scheme S1, Structures and spacer lengths of cross-
linkers used in this study. Table S1, Summary of cross-
linked products (intra- and intermolecular) for CaM and
skMLCK peptide. For SBC, irradiation energies are indicated
(4 or 8 J/cm2. Table S2, Summary of cross-linked
products (intra- and intermolecular) for CaM and
skMLCK F19A peptide. For SBC, irradiation energies are
indicated (4 or 8 J/cm2). Table S3, Summary of cross-linked
products (intra- and intermolecular) for CaM and
skMLCK F19E peptide. For SBC, irradiation energies are
indicated (4 or 8 J/cm2). Table S4, Summary of cross-linked
products (intra- and intermolecular) for CaM and
skMLCK F19E/L31W peptide. For SBC, irradiation energies
are indicated (4 or 8 J/cm2).
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